Mustang Bio reports third quarter 2017 financial results
Mustang Bio reported the net loss attributable to common stockholders was $6.9 million, or $0.27 per share, for the 2017 third quarter versus a net of $1.9 million, or $0.19 per share, for the same 2016 quarter. As of Sept. 30, 2017, Mustang’s cash and short-term investments totaled $67.3 million. November 14, 2017